Enter your login e-mail to the account
Search
- New trends in metastatic hormone-sensitive prostate cancer treatment
prof. MUDr. Ján Kliment, CSc.
(2/2020, Interdisciplinary consilium )
- New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Non-metastatic castration-resistant prostate cancer
MUDr. Jana Katolická, Ph.D.
(2/2022, Review articles ) - Current treatment management of non-metastatic castration-resistant prostate cancer
MUDr. Nikol Rušarová, MUDr. Hana Študentová, Ph.D.
(1/2020, Review articles ) - Prostate cancer – interaction potential of used drugs
PharmDr. Roman Goněc, PharmDr. Vojtěch Ondra, Doc. PharmDr. Jan Juřica, Ph.D.
(2/2025, Drug interaction ) - Treatment of non-metastatic castration-resistant prostate cancer
MUDr. Ivo Kocák, Ph.D.
(4/2020, Review articles ) - The role of ARTAs in treating metastatic castration-resistant prostate cancer
MUDr. PharmDr. Jan Dvořák
(2/2019, Review articles )
- Non-metastatic castration-resistant prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2019, Review articles ) - Current treatment options for metastatic hormone-sensitive prostate cancer
MUDr. Jana Obertová, PhD.
(4/2023, Main topic ) - Review on castrate-resistant prostate carcinoma systemic therapy
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2023, Main topic ) - Optimization of radiotherapy of high-risk prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(5/2019, Main topic ) - A comprehensive view of the treatment of metastatic hormone sensitive prostate cancer
prof. MUDr. Ján Kliment, CSc., MUDr. Ing. Monika Kuzma, MBA
(5/2019, Main topic ) - Novinky z ASCO 2026
MUDr. Mária Rečková, PhD.
(4/2026, Events ) - Bratislavské onkologické dni LXI. ročník- Odborný program a abstrakty
Kolektív autorov
(S3/2024, Abstracts ) - Metastatický hormonálne senzitívny karcinóm prostaty
prof. MUDr. Ján Kliment, CSc.
(S5/2024, Editorial ) - Current trends in the treatment of metastatic hormone-sensitive prostate cancer – a case report
MUDr. Abdullah Dammak, MBA, MUDr. Bc. Viera Dammak, MBA
(S5/2024, Case reports ) - Efficacy and tolerance of ARTA treatment in a patient with metastatic hormone-sensitive prostate cancer
MUDr. Filip Kohútek, PhD.
(S5/2024, Case reports ) - Efficacy of darolutamide in the treatment castration sensitive prostate cancer
MUDr. Peter Leško, PhD.
(4/2024, Drugs & drug classes ) - First-line treatment of metastatic castration-sensitive prostate cancer
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M., MUDr. Ján Slopovský
(3/2022, Review articles ) - Management of PSA progression after topical treatment of prostate cancer
doc. MUDr. Pavol Dubinský, PhD., MHA
(S1/2020, Case reports ) - Androgen deprivation therapy and radiotherapy of prostate cancer
doc. MUDr. Pavol Dubinský, PhD.
(5/2018, Review articles )